Benjamin J. Samelson‐Jones

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates